AprilBio Co (397030.KQ) Stock Price

AprilBio Co Price

CLOSED
14,560.00
​
Market closed

Revenue has compounded at 56.1% per year over the past 6 years to 2.17 B KRW. AprilBio Co's net margin stands at -447.9%, down from -225.3% several years earlier. Analysts set a median price target of 47,430.00 KRW, implying 225.8% above the current price. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.

AprilBio Co stock price

Access this data via the Eulerpool API

AprilBio Co business model & stock analysis

Aprilbio Co. Ltd. develops long-action proteins and antibody drugs. The company is headquartered in Chuncheon, Gangwon-Do and currently employs 24 full-time employees. The company went IPO on 2022-07-28. The firm is primarily engaged in the bio-innovative new drug research and development (R&D) business such as antibody therapeutics and long-acting recombinant protein pharmaceuticals.

Frequently asked questions about AprilBio Co

Analysts currently set an average price target of 47,430.00 KRW for the AprilBio Co stock (median: 47,430.00 KRW), implying +225.8 % versus the latest price. The consensus is based on 6 analyst ratings.

7 analysts currently rate the AprilBio Co stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect AprilBio Co to generate revenue of 13.00 B KRW and earnings per share of -1,159.84 KRW.

Converted at the current exchange rate, the AprilBio Co share trades at 9.68 EUR (14,560.00 KRW).

The expected revenue of AprilBio Co is 13.00 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of AprilBio Co is -26.92 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of AprilBio Co is currently -12.55. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the AprilBio Co stock.

The price-to-sales ratio (P/S) of AprilBio Co is currently 25.99. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the AprilBio Co stock.

The Eulerpool Quality Score for AprilBio Co is 2/10.

The ISIN of AprilBio Co is KR7397030008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of AprilBio Co is 397030.KQ. The ticker symbol is used to trade AprilBio Co shares on the stock exchange.

Fair ValueTerminal
15,142.40 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
90.50 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website aprilbio.com
Country
South Korea
Currency
KRW
Initial public offering
Jul 28, 2022
ISIN
KR7397030008
Cusip
Y0S1C6104
Market capitalization
329.90 B KRWMega Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-12.55
P/Ee 2027
-15.62
P/Se
25.99
EV/EBIT
—
P/B Ratio
3.43
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-10.05 %
Last updated Oct 10, 2026, 7:56 PM

AprilBio Co Peer Group

AprilBio Co FIGI

397030:KS · BBG00XV9W0R8397030:KQ · BBG018BW1MV4

All fundamentals and in-depth analysis of AprilBio Co

Our stock analysis for AprilBio Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AprilBio Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.